Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Julie Gralow

Tracked across 4 events · 215 articles · First seen May 29, 2026 · Last active Aug 26, 2026

Sentiment
45
Attention
7
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 50
Tech
Impact: Julie Gralow>>>, chief medical officer of American Society of Clinical Oncology>>>, highlights the future need for full genomic profiling of every cancer.
Jun 03, 2026 · 6 articles
7 70
Tech
Impact: Julie Gralow, chief medical officer at American Society of Clinical Oncology, called the Daraxonrasib findings a 'grand slam' due to the drug's ability to target the KRAS mutation in Pancreatic cancer.
May 29, 2026 · 74 articles
2 5
Domestic
Impact: ASCO Chief Medical Officer who highlighted the need for locally generated evidence.
Jul 11, 2026 · 9 articles
7 55
Tech
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy Pembrolizumab, met its primary and secondary endpoints in a Phase 3 trial involving 1,137 patients…
Impact: As chief medical officer of ASCO, Gralow called the trial result 'a monumental leap forward,' validating mRNA technology as a cancer treatment.
Aug 19, 2026 · 126 articles
ERGEN INTELLIGENCE
Track Julie Gralow live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.